Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Railcare Group | RAIL | Mar 18, 2024 | 24.70 | +1.23 |
Railway Metrics and Dynamics Sweden AB | RMDX | Mar 18, 2024 | 2.08 | -5.45 |
Raketech | RAKE | Mar 18, 2024 | 15.92 | -0.62 |
Rana Gruber ASA | RANAO | Mar 18, 2024 | 72.30 | +2.55 |
RanLOS | RLOSB | Mar 18, 2024 | 7.13 | 0.00 |
Ranplan Group | RPLAN | Mar 18, 2024 | 1.17 | -2.50 |
Ratos A | RATOA | Mar 18, 2024 | 36.05 | +0.14 |
Ratos B | RATOB | Mar 18, 2024 | 34.16 | -0.23 |
RaySearch Laboratories B | RAYB | Mar 18, 2024 | 107.20 | +1.90 |
Raytelligence | RAYTL | Mar 18, 2024 | 0.01 | 0.00 |
Readly International | READ | Mar 18, 2024 | 14.06 | -2.36 |
RealFiction | REALFI | Mar 18, 2024 | 16.20 | -0.61 |
Reato Group AB | REATO | Mar 18, 2024 | 1.33 | 0.00 |
Recyctec B | RECYB | Mar 18, 2024 | 0.43 | +1.90 |
Rederi Gotland AB | GOTLA | Mar 18, 2024 | 2 300.00 | +10.58 |
Rederi Gotland AB. ser. B | GOTLB | Mar 18, 2024 | 2 300.00 | +8.49 |
Redsense Medical | REDS | Mar 18, 2024 | 6.30 | -5.12 |
Redwood Pharma | REDW | Mar 18, 2024 | 1.95 | +2.09 |
Refine Group | REFINE | Mar 18, 2024 | 1.85 | 0.00 |
Rejlers B | REJLB | Mar 18, 2024 | 142.00 | +3.27 |
Renewable Ventures Nordic | RVN | Mar 18, 2024 | 6.40 | 0.00 |
ReNewCell | RENEW | Mar 18, 2024 | 0.00 | 0.00 |
Rentunder Holding | RENT | Mar 18, 2024 | 0.32 | -6.47 |
Respiratorius | RESP | Mar 18, 2024 | 0.23 | +1.32 |
Resqunit | RESQ | Mar 18, 2024 | 0.82 | 0.00 |
Resurs Holding | RESURS | Mar 18, 2024 | 14.45 | +0.84 |
Revolutionrace | RVRC | Mar 18, 2024 | 66.15 | -1.49 |
RightBridge Ventures Group | RIGHTB | Mar 18, 2024 | 0.03 | -0.34 |
Risk Intelligence | RISK | Mar 18, 2024 | 0.94 | -0.53 |
Rizzo Group B | RIZZOB | Mar 18, 2024 | 0.03 | -16.01 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.